Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Second Hospital of Anhui Medical University
Hefei, Anhui, China
Recruiting - Zhejiang Provincial People'S Hospital
Hangzhou, Zhejiang, China
Recruiting - Eye Hospital, Wmu (zhejiang Eye Hospital)
Wenzhou, Zhejiang, China
Recruiting - Beijing Hospital
Beijing, China
Recruiting - Peking Union Medical College Hospital
Beijing, China
Recruiting
- Retina Vitreous Associates of Florida - Saint Petersburg
St. Petersburg, Florida, United States
Not, yet, recruiting - Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
Recruiting - Retina Consultants of Texas
Katy, Texas, United States
Charles C Wykoff, MDRecruiting - Wagner Kapoor Research Institute
Norfolk, Virginia, United States
Alan Wagner, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Feb 2024
- Primary completion
- 31 Jan 2026
- Completion
- 30 Jan 2026
- Last update posted
- 9 Jan 2025
- Registered enrollment
- 68
- Registry id
- NCT05986864
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.